We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
-9.41%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$982M
AUM Growth
+$21.4M
Cap. Flow
+$184M
Cap. Flow %
18.72%
Top 10 Hldgs %
37.6%
Holding
143
New
43
Increased
40
Reduced
5
Closed
15

Top Buys

Rank Stock Value
1
DVAX
Dynavax Technologies
DVAX
+$29.1M
2
ANIP icon
ANI Pharmaceuticals
ANIP
+$19.5M
3
ACAD icon
Acadia Pharmaceuticals
ACAD
+$15.8M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$15.4M
5
TDOC icon
Teladoc Health
TDOC
+$12.2M

Top Sells

Rank Stock Value
1
INBX
Inhibrx, Inc. Common Stock
INBX
+$24.5M
2
MOR
MorphoSys AG American Depositary Shares
MOR
+$14.5M
3
DCPH
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
+$9.44M
4
NTLA icon
Intellia Therapeutics
NTLA
+$5.5M
5
BLUE
bluebird bio
BLUE
+$3.2M

Sector Composition

Rank Sector Weight
1 Healthcare 95.92%
2 Technology 1.53%
3 Real Estate 0.71%
4 Communication Services 0.66%
5 Financials 0.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PBYI icon
101
Puma Biotechnology
PBYI
$454M
$652K 0.07%
+200,000
New +$878K
ATRA icon
102
Atara Biotherapeutics
ATRA
$76.1M
$639K 0.07%
75,196
-1
-0% -$15
ALGS icon
103
Aligos Therapeutics
ALGS
$34.9M
$578K 0.06%
66,000
– –
JPM icon
104
JPMorgan Chase
JPM
$950B
$366K 0.04%
+1,811
New +$354K
MSFT icon
105
Microsoft
MSFT
$3.71T
$364K 0.04%
+814
New +$344K
WMT icon
106
Walmart Inc
WMT
$890B
$302K 0.03%
+4,460
New +$281K
BRK.B icon
107
Berkshire Hathaway Class B
BRK.B
$1.13T
$289K 0.03%
+711
New +$291K
NFLX icon
108
Netflix
NFLX
$309B
$288K 0.03%
+4,270
New +$267K
V icon
109
Visa
V
$677B
$275K 0.03%
+1,049
New +$288K
PG icon
110
Procter & Gamble
PG
$339B
$254K 0.03%
+1,543
New +$252K
VTRS icon
111
Viatris
VTRS
$18.9B
$235K 0.02%
+22,080
New +$244K
TXN icon
112
Texas Instruments
TXN
$261B
$234K 0.02%
+1,204
New +$222K
HD icon
113
Home Depot
HD
$355B
$234K 0.02%
+679
New +$232K
AXP icon
114
American Express
AXP
$230B
$232K 0.02%
+1,001
New +$232K
INTC icon
115
Intel
INTC
$513B
$228K 0.02%
+7,354
New +$241K
KO icon
116
Coca-Cola
KO
$375B
$227K 0.02%
+3,561
New +$220K
AMZN icon
117
Amazon
AMZN
$2.96T
$225K 0.02%
+1,164
New +$214K
IVVD icon
118
Invivyd
IVVD
$218M
$220K 0.02%
+200,000
New +$442K
GE icon
119
GE Aerospace
GE
$384B
$220K 0.02%
+1,383
New +$221K
XOM icon
120
ExxonMobil
XOM
$634B
$220K 0.02%
+1,908
New +$222K
VZ icon
121
Verizon
VZ
$196B
$219K 0.02%
+5,308
New +$214K
DIS icon
122
Walt Disney
DIS
$181B
$201K 0.02%
+2,029
New +$218K
ALL icon
123
Allstate
ALL
$67.5B
$201K 0.02%
+1,260
New +$210K
AMLX icon
124
Amylyx Pharmaceuticals
AMLX
$2.54B
$190K 0.02%
100,000
– –
F icon
125
Ford
F
$55.7B
$160K 0.02%
+12,773
New +$158K
2 3 4
5
6

Similar funds

HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
RMCM
Reynders McVeigh Capital Management Boston, Massachusetts $1.98B AUM 23.37% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return
SC
Syon Capital San Francisco, California $1.99B AUM 22.67% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BC
Blackhill Capital Morristown, New Jersey $1.94B AUM 18.09% 1-Year Est. Return
FFH
Fairfax Financial Holdings Toronto, Ontario, Canada $1.94B AUM 27.76% 1-Year Est. Return

Tang Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Tang Capital Management held 143 positions worth $982M, up 2.2% from $960M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tang Capital Management deployed $184M of net new capital in Q2 2024, opening 43 new positions and adding to 40 existing holdings. Its largest new stake was Dynavax Technologies: 2,500,000 shares worth $28.1M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, down from 98% a quarter earlier, followed by Technology and Real Estate.

On the sell side, the largest reduction was Quince Therapeutics, an estimated $1.31M trimmed.

  • Tang Capital Management's largest Q2 2024 buy was Dynavax Technologies: 2,500,000 shares worth $28.1M.
  • Tang Capital Management added most to ANI Pharmaceuticals in Q2 2024, an estimated $19.5M increase.
  • Tang Capital Management's biggest Q2 2024 reduction was Quince Therapeutics, cutting an estimated $1.31M.
  • Tang Capital Management fully exited Inhibrx, Inc. Common Stock in Q2 2024, selling an estimated $24.5M.
  • Tang Capital Management's ten largest holdings make up 38% of its $982M portfolio in Q2 2024.
  • Tang Capital Management opened 43 new positions and closed 15 in Q2 2024.
  • Tang Capital Management's portfolio value rose 2.2% quarter-over-quarter to $982M.

Based on Tang Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.